1/1

Retatrutide 5mg+cagrilintide 5mg

Explore the Retatrutide 5mg + Cagrilintide 5mg complex peptides to learn about their role in lipolysis, appetite suppression, and metabolic management. CAS: 2381089-83-2 (Retatrutide) / 1415456-99-3 (Cagrilintide) Purity: 99%

Product Description

This product is a cutting-edge, multi-modal composite weight management peptide formulation scientifically proportioned with Retatrutide (5mg) and Cagrilintide (5mg). This advanced stack perfectly integrates two complementary metabolic-regulating active peptides. Retatrutide acts as an innovative triple hormone receptor agonist that simultaneously stimulates GLP-1, GIP, and glucagon (GCGR) receptors with balanced activity. Cagrilintide serves as a long-acting acylated amylin analogue primarily targeting central satiety pathways. Designed to achieve multi-level regulation between peripheral energy expenditure and central appetite suppression, this unique synergistic composition operates as a core metabolic agent for intensive weight management and cellular homeostasis.

Product benefits

Proponents and researchers of this composite peptide supplement state that it can drastically accelerate adipose tissue lipolysis, extend satiation windows, and successfully break through stubborn metabolic plateaus. This is because its unique four-fold dynamic mechanism (GLP-1R / GIPR / GCGR / AMYR) optimizes the signaling microenvironments of the gastrointestinal tract, pancreas, and hypothalamus—when single-target mechanisms experience adaptive deceleration, this stack dual-activates central appetite blockade and systemic thermogenesis.

Triple-Target Comprehensive Lipolysis (Retatrutide 5mg): Beyond the traditional appetite control and delayed gastric emptying mediated via GLP-1/GIP pathways, Retatrutide specifically upregulates the glucagon receptor (GCGR) to enhance hepatic lipid oxidation and elevate baseline energy expenditure. This mechanism ensures high-efficiency calorie burning even during caloric deficits. [1]

Deep Central Satiety and Synergistic Satiation (Cagrilintide 5mg): Functioning as a non-selective amylin and calcitonin receptor agonist, Cagrilintide induces a distinct sensation of fullness via independent hindbrain pathways. It significantly slows gastric emptying and dampens hedonic food cravings, creating a powerful “1+1>2” synergy alongside Retatrutide. [1]

Overcoming Metabolic Plateaus for Long-Term Management: Both peptides are deeply involved in resetting the body’s metabolic set-point. Scientists are actively investigating its potential links to bypassing natural dietary resistance, promoting fat loss in stubborn biological profiles, and restoring metabolic flexibility.